Stocks TelegraphStocks Telegraph
Stock Ideas

MRES Company Profile and Key Details

PNK : MRES

Institute of Biomedical Research

$0.01
-0.002-22.22%
At Close 4:00 PM

Price Chart

Stock Price Today

Institute of Biomedical Research Corp. (MRES) stock declined over -24.32%, trading at $0.00 on OTC, down from the previous close of $0.00. The stock opened at $0.00, fluctuating between $0.00 and $0.00 in the recent session.

Stock Snapshot

0.0037
Prev. Close
7.7M
Market Cap
0.0028
Day Low
-0.01
P/E Ratio
-0.5
EPS (TTM)
-0.05
Cash Flow per Share
0
Open
2.75B
Number of Shares
0.0034
Day High
39.96%
Free Float in %
-0.06
Book Value
785K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Sep 10, 20260.000.000.000.00992.7K
Sep 09, 20260.000.000.000.001.6M
Sep 08, 20260.000.000.000.001.43M
Sep 04, 20260.000.000.000.002.14M
Sep 03, 20260.000.000.000.001.11M
Sep 02, 20260.000.000.000.005.99M
Sep 01, 20260.000.000.000.003.16M
Aug 31, 20260.000.000.000.002.13M
Aug 28, 20260.000.000.000.006.11M
Aug 27, 20260.000.000.000.0014.25M
Aug 24, 20260.000.000.000.0048.96K
Aug 20, 20260.000.000.000.00421.68K
Aug 19, 20260.000.000.000.002.64M
Aug 18, 20260.000.000.000.001.08M
Aug 17, 20260.000.000.000.0060K
Aug 14, 20260.000.000.000.003.95M
Aug 13, 20260.000.000.000.00705.68K
Aug 12, 20260.000.000.000.001.9M
Aug 10, 20260.000.000.000.004.39M
Aug 06, 20260.000.000.000.00583.18K

Contact Details

Podgorica, DU 81000

Montenegro

https://mrescorp.com382 206 63075

About Company

Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical products, advanced technologies, and innovative diagnostic methods, including experimental medical treatments. MRES also focuses on the creation of novel biomedical and food products. A significant part of its mandate involves regulatory oversight of industrial activities and their associated products, alongside scientific environmental monitoring. Furthermore, it delivers expert regulatory evaluation and certification services for a wide array of biomedical products. The institute also contributes to academic advancement through graduate research study programs in the biomedical and environmental fields. MRES manufactures and supplies a diverse range of healthcare devices. Its offerings include two-channel analog NMS units, various digital muscle stimulators, digital TENS devices, interferential therapy units, elite combination models, portable four-channel digital stimulators, and portable ultrasound equipment. The product portfolio also extends to photon red light devices for aesthetic applications, electric pain relief solutions, microcurrent electrical nerve stimulators, and high-volt pulsed stimulators. The company excels in the development and commercialization of specialized agents and products. This category features microbicidal agents, a variety of disinfectant solutions, and specialized medical supplies such as bandages tailored for severe burns. They also provide products for hard surface disinfection, microbicidal treatments for fabrics and textiles, insecticides (including those targeting bed bugs), microbicidal towels, and mouthwash. Key innovations include Purilair, an apparatus specifically designed for sterilizing compressed air within medical instruments, alongside colloidal silver and other electro-medical devices. A notable product is BioStim INF, which is engineered for reducing edema, alleviating pain, and delivering comprehensive therapeutic benefits. Beyond its product and research endeavors, MRES offers a broad spectrum of essential services. These include quality control, regulatory assistance, healthcare support, environmental analysis, building decontamination, and extensive environmental protection and management services. They are also a critical source for regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was established in 2010 and maintains its headquarters in Podgorica, Montenegro, with a representative office located in Montreal, Canada, facilitating its global operations.

Company Information

Employees5
Beta-0.64
Sales or RevenueN/A
5Y Sales Change%0%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Institute of Biomedical Research Corp. (MRES) stock price?
Institute of Biomedical Research Corp. (OTC: MRES) stock price is $0.00 in the last trading session. During the trading session, MRES stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in MRES stock occurred in the recent session was -24.32% while the dollar amount for the price change in MRES stock was - $0.00.
MRES's industry and sector of operation?
The OTC listed MRES is part of Biotechnology industry that operates in the broader Healthcare sector. Institute of Biomedical Research Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of MRES?
Dr. Drasko D. Pekovic
Founder, Chairman, Chief Executive Officer & Pres
Mr. Teodor Burtea
Director & Member of Scientific Council
How MRES did perform over past 52-week?
MRES's closing price is 70.73% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.02 is -75%.
How many employees does MRES have?
Number of MRES employees currently stands at 5.
Link for MRES official website?
Official Website of MRES is: https://mrescorp.com
How do I contact MRES?
MRES could be contacted at phone 382 206 63075 and can also be accessed through its website. MRES operates from Ljubljanska bb, Podgorica, DU 81000, Montenegro.
How many shares of MRES are traded daily?
MRES stock volume for the day was 785K shares. The average number of MRES shares traded daily for last 3 months was 1.61M.
What is the market cap of MRES currently?
The market value of MRES currently stands at $7.70M with its latest stock price at $0.00 and 2.75B of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph